Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphoma, with different clinical manifestation and prognosis. The International Prognostic Index (IPI), an index designed during the prerituximab era for aggressive lymphoma, showed variable values in the prediction of patient clinic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mediators Inflamm
Autores principales: Shi, Qing, Shen, Rong, Wang, Chao-Fu, Fan, Xing, Qian, Ying, Ou-Yang, Bin-Shen, Zhao, Yan, Leboeuf, Christophe, Janin, Anne, Cheng, Shu, Wang, Li, Zhao, Wei-Li
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5646333/
https://ncbi.nlm.nih.gov/pubmed/29109622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7960907
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares